Company news
Kiora Pharmaceuticals, Inc. news in 2021
Kiora Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
December 14, 2021
Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease
December 13, 2021
Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
November 14, 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 26 slides · November 2021
- EyeGate Pharmaceuticals — Investor Presentation (September 2021)
Investor deck · 30 slides · Sep 14, 2021
- Eyegate Pharmaceuticals — Investor Presentation (May 2021)
Investor deck · 36 slides · May 27, 2021